Indian Journal of Psychiatry · 2009 · 39 citations · 59 references
PharmacyPharmacotherapyPsychiatryClinical PharmacologyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapySchizophrenia PharmacotherapySchizophrenia Spectrum DisordersTreatment Of Mental DisordersAntipsychotic Medication ManagementAntipsychotic Medication UseClozapine PharmacologyDiagnostic Criteria PrevalenceOlanzapine PharmacologyPsychosis PharmacotherapyRisperidone PharmacologyRisperidone Therapy
This article summarizes the current knowledge base on the diagnosis and management of treatment resistant schizophrenia. While the prevalence of treatment resistant schizophrenia is definition dependent, estimates have ranged from 30% to up to 60%. This article first looks into the various diagnostic criteria of treatment resistant schizophrenia. Then the literature is reviewed about the pharmacotherapeutics of its management. Clozapine emerges to be the gold standard. In addition risperidone and high dose olanzapine also emerge as clinically useful options. Other emerging adjunctive treatment options are equally addressed.
59
Clozapine for the Treatment-Resistant Schizophrenic
John M. Kane · Archives of General Psychiatry · 1988 · 4.1K citations
Medicine, Pharmacology, Psychiatry +16
Joseph P. McEvoy, Jeffrey A. Lieberman, T. Scott Stroup et al. · American Journal of Psychiatry · 2006 · 755 citations